Exclusive-Kennedy's new vaccine adviser was expert witness against Merck vaccine

Exclusive-Kennedy's new vaccine adviser was expert witness against Merck vaccine
Exclusive-Kennedy's new vaccine adviser was expert witness against Merck vaccine
Exclusive-Kennedy's new vaccine adviser was expert witness against Merck vaccine
Analysis-Kennedy’s ouster of US vaccine advisers puts pharma ties under scrutiny
Analysis-Kennedy’s ouster of US vaccine advisers puts pharma ties under scrutiny
Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
NIH director hopes to settle with US universities over suspended grants
NIH director hopes to settle with US universities over suspended grants
Factbox-Vaccine actions and policy positions under US Health Secretary Kennedy
Factbox-Vaccine actions and policy positions under US Health Secretary Kennedy
Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say
Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say
South Africa to ramp up vaccinations as foot-and-mouth disease spreads
South Africa to ramp up vaccinations as foot-and-mouth disease spreads
CDC official resigns from COVID vaccine committee advisory role, sources say
CDC official resigns from COVID vaccine committee advisory role, sources say
US CDC keeps COVID vaccine option for healthy children
US CDC keeps COVID vaccine option for healthy children
US cancels more than $700 million funding for Moderna bird flu vaccine
US cancels more than $700 million funding for Moderna bird flu vaccine
Argentina to review use of fast-track authorizations for costly drugs
Argentina to review use of fast-track authorizations for costly drugs
Animal health body says vaccines needed to protect humans and trade
Animal health body says vaccines needed to protect humans and trade
COVID shots should target newer strains of JN.1 variant, US FDA advisers say
COVID shots should target newer strains of JN.1 variant, US FDA advisers say